Differential desensitization of μ‐ and δ‐ opioid receptors in selected neural pathways following chronic morphine treatment
Open Access
- 1 January 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 117 (1) , 161-169
- https://doi.org/10.1111/j.1476-5381.1996.tb15169.x
Abstract
1 Morphine produces a plethora of pharmacological effects and its chronic administration induces several side-effects. The cellular mechanisms by which opiates induce these side-effects are not fully understood. Several studies suggest that regulation of adenylyl cyclase activity by opioids and other transmitters plays an important role in the control of neural function. 2 The aim of this study was to evaluate desensitization of μ- and δ- opioid receptors, defined as a reduced ability of opioid agonists to inhibit adenylyl cyclase activity, in four different brain structures known to be involved in opiate drug actions: caudate putamen, nucleus accumbens, thalamus and periaqueductal gray (PAG). Opiate regulation of adenylyl cyclase in these regions has been studied in control and morphine-dependent rats. 3 The chronic morphine treatment used in the present study (subcutaneous administration of 15.4 mg morphine/rat/day for 6 days via osmotic pump) induced significant physical dependence as indicated by naloxone-precipitated withdrawal symptoms. 4 Basal adenylyl cyclase in the four brain regions was not modified by this chronic morphine treatment. In the PAG and the thalamus, a desensitization of μ- and δ-opioid receptors was observed, characterized by a reduced ability of Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol (DAMGO; μ), Tyr-D-Pen-Gly-Phe-D-Pen(DPDPE; δ) and [D-Ala2]-deltorphin-II (DT-II; μ) to inhibit adenylyl cyclase, activity following chronic morphine treatment. 5 The opioid receptor desensitization in PAG and thalamus appeared to be heterologous since the metabotropic glutamate receptor agonists, L-AP4 and glutamate, and the 5-hydroxytryptamine (5-HT)1A receptor agonist, R(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT), also showed reduced inhibition of adenylyl cyclase activity following chronic morphine treatment. 6 In the nucleus accumbens and the caudate putamen, desensitization of δ-opioid receptor-mediated inhibition without modification of μ-opioid receptor-mediated inhibition was observed. An indirect mechanism probably involving dopaminergic systems is proposed to explain the desensitization of δ-mediated responses and the lack of μ-opioid receptor desensitization after chronic morphine treatment in caudate putamen and nucleus accumbens. 7 These results suggest that adaptive responses occurring during chronic morphine administration are not identical in all opiate-sensitive neural populations.Keywords
This publication has 48 references indexed in Scilit:
- Differential Regulation of D1 Dopamine Receptor‐ and of A2a Adenosine Receptor‐Stimulated Adenylyl Cyclase by μ‐, δ1‐, and δ2‐Opioid Agonists in Rat Caudate PutamenJournal of Neurochemistry, 1995
- Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNAEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- The effect of thalamic nucleus submedius lesions on nociceptive responding in ratsPain, 1994
- Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Drug addiction: A model for the molecular basis of neural plasticityNeuron, 1993
- Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering μ-opioid receptor sensitivityLife Sciences, 1993
- Regulation of G proteins by chronic morphine in the rat locus coeruleusBrain Research, 1989
- Morphine-induced desensitization and down-regulation at mu-receptors in 7315c pituitary tumor cellsLife Sciences, 1989
- Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndromeLife Sciences, 1987
- Development of cross-tolerance to 5-hydroxytryptamine in organotypic cultures of mouse spinal cord-ganglia during chronic exposure to morphineLife Sciences, 1982